Advertisements



Esperion Therapeutics Inc (ESPR): Get It While It’s Cheap

At the end of last week, Amgen, Inc. (NASDAQ:AMGN) announced some data from its large-scale trial of its cardiovascular risk asset Repatha.....»»

Category: topSource: insidermonkeyMar 20th, 2017

Esperion Therapeutics Becomes Oversold (ESPR)

Dividend Channel.....»»

Category: topSource: redinewsOct 23rd, 2017

Esperion Therapeutics" (ESPR) CEO Tim Mayleben on Q2 2017 Results - Earnings Call Transcript

Esperion Therapeutics" (ESPR) CEO Tim Mayleben on Q2 2017 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaAug 8th, 2017

Esperion Therapeutics (ESPR) Looks Good: Stock Gains 10.4%

Esperion Therapeutics, Inc. (ESPR) shares jumped a little above 10% in the last trading session. Esperion Therapeutics, Inc. ESPR was a big mover last sess.....»»

Category: topSource: zacksJun 29th, 2017

Here"s Why Shares of Esperion Therapeutics (ESPR) Popped Today

In a week full of good news f.....»»

Category: topSource: zacksJun 28th, 2017

Esperion"s Combo Cholesterol Candidate Enters Phase III

Esperion Therapeutics, Inc. (ESPR) received positive feedback from the FDA for initiation of a phase III bridging study, evaluating the combination of bempedo.....»»

Category: topSource: zacksJun 28th, 2017

EAM Investors, LLC Buys NewLink Genetics Corp, Teladoc Inc, Esperion Therapeutics Inc, Sells ...

Related Stocks: BRKS, FLXN, AQMS, DERM, SN, UCTT, NLNK, TDOC, ESPR, EXTR, TV,.....»»

Category: smallbizSource: nytMay 10th, 2017

Esperion Therapeutics (ESPR) Presents At ACC 66th Annual Scientific Session (Genetic Validation of ACL) - Slideshow

Esperion Therapeutics (ESPR) Presents At ACC 66th Annual Scientific Session (Genetic Validation of ACL) - Slideshow.....»»

Category: topSource: seekingalphaMar 20th, 2017

Esperion Therapeutics (ESPR) Jumps: Stock Moves Up 8.6%

Zacks.....»»

Category: topSource: redinewsMar 9th, 2017

Esperion Therapeutics (ESPR) Jumps: Stock Moves Up 8.6%

Esperion Therapeutics, Inc. (ESPR) moved big last session, as its shares rose above 8% on the day. .....»»

Category: topSource: zacksMar 9th, 2017

Esperion Provides Bempedoic Acid Development Program Update; Reports Fourth Quarter and Full Year 2016 Financial Results

ANN ARBOR, Mich., Feb. 22, 2017 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the lipid management company focused on d.....»»

Category: earningsSource: benzingaFeb 22nd, 2017

Esperion Surge May Be Fueled By Repatha Short Squeeze

Esperion Therapeutics Inc (NASDAQ: ESPR) has maintained its upward momentum on Tuesday, surging higher by another 13.2 percent. read more.....»»

Category: blogSource: benzingaFeb 7th, 2017

What’s Next For Esperion Therapeutics Inc (ESPR)?

Esperion Therapeutics Inc (NASDAQ:ESPR) picked up strength at the end of last week, on the back of some news that – at first glance – seems unr.....»»

Category: topSource: insidermonkeyFeb 6th, 2017

Esperion Therapeutics (ESPR) Presents At 35th Annual J.P. Morgan Healthcare Conference

Esperion Therapeutics (ESPR) Presents At 35th Annual J.P. Morgan Healthcare Conference.....»»

Category: topSource: seekingalphaJan 11th, 2017

Esperion Therapeutics Inc (ESPR): Smart Money Doubles Down

You probably know from experience that there is not as much information on small-cap companies as there is on large companies. Of course, this makes it really hard and difficult for individual investors to make proper and accurate analysis of certain smal.....»»

Category: topSource: insidermonkeyDec 9th, 2016

Top-Line Data For Esperion"s Bempedoic Acid Creates Question About Whether There Is A Place In The Market For It

Following the release of top-line results from the eight-week mid-state study of Esperion Therapeutics Inc (NASDAQ: ESPR)'s bempedoic acid, Chardan said safety concerns on adding it to high-dose statins triggers a question whether there is any market for .....»»

Category: blogSource: benzingaOct 13th, 2016

Esperion Therapeutics (ESPR) in Focus: Stock Jumps 18.1%

Zacks.....»»

Category: topSource: redinewsSep 21st, 2016

Esperion Therapeutics (ESPR) in Focus: Stock Jumps 18.1%

Esperion Therapeutics, Inc. (ESPR) moved big last session, as its shares jumped a little over 18% on the day. Esperion Therapeutics, Inc. ESPR was a big mover last session, as its shares rose a little over 18% on the day. The move came on solid.....»»

Category: topSource: zacksSep 21st, 2016

Esperion Therapeutics Remains Undervalued

Esperion Therapeutics Remains Undervalued.....»»

Category: topSource: seekingalphaSep 21st, 2017

3 Top Biotech Stocks Under $10

Celldex Therapeutics, Insys Therapeutics, and Novavax might not be so cheap over the long run......»»

Category: topSource: foxnewsAug 19th, 2017

3 Been-There-Done-That Biotech CEOs Who Are Doing it Again

After Puma Biotech's recent success, the search is on for other clinical-stage biotechs being run by proven CEOs. Could leadership experience turn Aurinia Pharmaceuticals, Axovant Sciences, and Esperion Therapeutics into winners too?.....»»

Category: topSource: foxnewsJul 21st, 2017